椎体形成術および骨盤形成術装置の世界市場成長 2024-2030Global Vertebroplasty and Kyphoplasty Device Market Growth 2024-2030 LPI(エルピーアイ情報)の最新調査によると、椎体形成術および骨盤形成術装置の世界市場規模は2023年に1億2,020万米ドルとなった。川下市場での需要拡大に伴い、椎体形成術および人工骨頭形成術装置は、レビュー... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリーLPI(エルピーアイ情報)の最新調査によると、椎体形成術および骨盤形成術装置の世界市場規模は2023年に1億2,020万米ドルとなった。川下市場での需要拡大に伴い、椎体形成術および人工骨頭形成術装置は、レビュー期間中のCAGRが3.6%で、2030年までに1億5,400万米ドルの再調整規模になると予測されています。この調査レポートは、世界の椎体形成術および骨盤形成術装置市場の成長の可能性を明らかにしています。椎体形成術と人工骨頭形成術装置は今後の市場で安定した成長を示すと予想される。しかし、椎体形成術および人工骨頭形成術装置の普及には、製品の差別化、コストの削減、サプライチェーンの最適化が引き続き重要です。市場関係者は、椎体形成術および人工骨頭形成術市場によってもたらされる莫大な機会を活用するために、研究開発に投資し、戦略的パートナーシップを構築し、進化する消費者の嗜好に合わせた製品を提供する必要があります。 椎体形成術と転子形成術は、椎体圧迫骨折(VCF)を治療するために行われる低侵襲の画像誘導外科手術です。VCFは、背中の痛み、身体活動の低下、抑うつ、自立心の喪失、肺活量の低下、睡眠困難などの原因となります。骨折した骨を支えるために、背中の骨(椎骨)に骨セメントを注入します。骨粗鬆症、血管奇形、またはあまり一般的ではありませんが、癌による骨折が椎骨に生じることがあります。椎体形成術と経皮形成術は、患者が機能的能力を回復し、さらなる椎体崩壊を避けるのに役立ちます。椎体形成術は、骨折を安定させ、高さを回復させ、変形を減少させることができる椎体形成術の高度なバージョンです。このレポートは、椎体形成術と骨形成術の装置市場を調査しています。 世界の椎体形成術および骨盤形成術装置の主要メーカーは、Medtronic、Stryker、J&J (Depuy Synthes)、Globus Medical、Merit Medicalなどです。世界の上位5社で約85%のシェアを占めている。北米が最大市場でシェア約55%、次いでアジア太平洋が約25%である。製品別では、前腕骨形成術が最大のセグメントで、約80%のシェアを占めている。また、用途別では病院が最も多く、次いで外来手術センターなどとなっている。 主な特徴 椎体形成術および骨盤形成術装置市場に関する本レポートは、様々な側面を反映し、業界に関する貴重な洞察を提供します。 市場規模と成長:この調査レポートは、椎体形成術およびキフォプラスティ装置市場の現在の規模と成長の概要を提供します。過去データ、タイプ別市場区分(例:ニードル、バルーン)、地域別内訳などが含まれます。 市場の促進要因と課題:当レポートでは、政府の規制、環境問題、技術の進歩、消費者の嗜好の変化など、椎体形成術および人工骨頭形成術装置市場の成長を促進する要因を特定・分析することができます。また、インフラストラクチャーの制限、範囲への不安、高額な初期費用など、業界が直面する課題も浮き彫りにすることができます。 競合情勢:この調査レポートは、椎体形成術および人工骨頭形成術装置市場内の競合状況の分析を提供しています。主要企業のプロフィール、市場シェア、戦略、製品提供などが含まれます。また、新興企業や市場に与える潜在的な影響にもスポットを当てています。 技術開発:この調査レポートは、椎体形成術および人工骨頭形成術装置産業における最新の技術開発を掘り下げることができます。これには、椎体形成術および人工骨頭形成術装置技術の進歩、椎体形成術および人工骨頭形成術装置の新規参入企業、椎体形成術および人工骨頭形成術装置の新規投資、椎体形成術および人工骨頭形成術装置の将来を形作るその他の技術革新が含まれます。 川下企業の好み:このレポートは、椎体形成術および骨形成術装置市場における顧客の購買行動と採用動向を明らかにします。このレポートには、顧客の購買決定、椎体形成術および人工骨頭形成術装置製品に対する嗜好に影響を与える要因が含まれています。 政府の政策とインセンティブ:この調査レポートは、政府の政策とインセンティブが椎体形成術および人工骨頭形成術装置市場に与える影響を分析しています。これには、規制の枠組み、補助金、税制優遇措置、椎体形成術および人工骨頭形成術装置市場の促進を目的としたその他の措置の評価が含まれます。また、市場成長促進におけるこれらの政策の有効性も評価します。 環境への影響と持続可能性この調査レポートは、椎体形成術および人工骨頭形成術装置市場の環境への影響と持続可能性の側面を評価しています。 市場予測と将来展望:調査レポートでは、実施した分析に基づいて、椎体形成術および人工骨頭形成術装置産業の市場予測と展望を提供しています。これには、市場規模、成長率、地域動向、技術進歩や政策展開に関する予測などが含まれます。 提言と機会:本レポートは、業界関係者、政策立案者、投資家への提言で締めくくられています。市場関係者が新たなトレンドを活用し、課題を克服し、椎体形成術および骨盤形成術装置市場の成長と発展に貢献するための潜在的な機会を強調しています。 市場の細分化 椎体形成術および人工骨頭形成術装置市場は、タイプ別および用途別に分割される。2019年から2030年までの期間について、セグメント間の成長により、タイプ別、用途別の消費額の正確な計算と予測を数量と金額で提供します。 タイプ別セグメント ニードル バルーン セメント混合・供給装置 用途別セグメント 病院 外来手術センター その他 本レポートではまた、市場を地域別に分けています: 南北アメリカ アメリカ カナダ メキシコ ブラジル APAC 中国 日本 韓国 東南アジア インド オーストラリア ヨーロッパ ドイツ フランス 英国 イタリア ロシア 中東・アフリカ エジプト 南アフリカ イスラエル トルコ GCC諸国 以下の企業は、一次専門家から収集した情報、および企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。 メドトロニック ストライカー デピューシンセ(ジョンソン・エンド・ジョンソン) グローバス・メディカル メリット・メディカル・システムズ BMKグローバルメディカル IZIメディカルプロダクツ ザベーション G21社 ジョライン スパインウェーブ テクニメド パンメッド バイオプシーベル 本レポートで扱う主な質問 椎体形成術および骨盤形成術装置の世界市場の10年見通しは? 椎体形成術および骨盤形成術装置の世界市場および地域別市場成長を促進する要因は何か? 市場別、地域別で最も急成長するのはどの技術か? 椎体形成術および骨盤形成術装置の市場機会は最終市場規模によってどのように異なるのか? 椎体形成術および骨盤形成術装置のタイプ別、用途別内訳は? 目次1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Vertebroplasty and Kyphoplasty Device Annual Sales 2019-2030 2.1.2 World Current & Future Analysis for Vertebroplasty and Kyphoplasty Device by Geographic Region, 2019, 2023 & 2030 2.1.3 World Current & Future Analysis for Vertebroplasty and Kyphoplasty Device by Country/Region, 2019, 2023 & 2030 2.2 Vertebroplasty and Kyphoplasty Device Segment by Type 2.2.1 Needles 2.2.2 Balloons 2.2.3 Cement Mixing and Delivery Devices 2.3 Vertebroplasty and Kyphoplasty Device Sales by Type 2.3.1 Global Vertebroplasty and Kyphoplasty Device Sales Market Share by Type (2019-2024) 2.3.2 Global Vertebroplasty and Kyphoplasty Device Revenue and Market Share by Type (2019-2024) 2.3.3 Global Vertebroplasty and Kyphoplasty Device Sale Price by Type (2019-2024) 2.4 Vertebroplasty and Kyphoplasty Device Segment by Application 2.4.1 Hospital 2.4.2 Ambulatory Surgery Center 2.4.3 Others 2.5 Vertebroplasty and Kyphoplasty Device Sales by Application 2.5.1 Global Vertebroplasty and Kyphoplasty Device Sale Market Share by Application (2019-2024) 2.5.2 Global Vertebroplasty and Kyphoplasty Device Revenue and Market Share by Application (2019-2024) 2.5.3 Global Vertebroplasty and Kyphoplasty Device Sale Price by Application (2019-2024) 3 Global Vertebroplasty and Kyphoplasty Device by Company 3.1 Global Vertebroplasty and Kyphoplasty Device Breakdown Data by Company 3.1.1 Global Vertebroplasty and Kyphoplasty Device Annual Sales by Company (2019-2024) 3.1.2 Global Vertebroplasty and Kyphoplasty Device Sales Market Share by Company (2019-2024) 3.2 Global Vertebroplasty and Kyphoplasty Device Annual Revenue by Company (2019-2024) 3.2.1 Global Vertebroplasty and Kyphoplasty Device Revenue by Company (2019-2024) 3.2.2 Global Vertebroplasty and Kyphoplasty Device Revenue Market Share by Company (2019-2024) 3.3 Global Vertebroplasty and Kyphoplasty Device Sale Price by Company 3.4 Key Manufacturers Vertebroplasty and Kyphoplasty Device Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Vertebroplasty and Kyphoplasty Device Product Location Distribution 3.4.2 Players Vertebroplasty and Kyphoplasty Device Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Vertebroplasty and Kyphoplasty Device by Geographic Region 4.1 World Historic Vertebroplasty and Kyphoplasty Device Market Size by Geographic Region (2019-2024) 4.1.1 Global Vertebroplasty and Kyphoplasty Device Annual Sales by Geographic Region (2019-2024) 4.1.2 Global Vertebroplasty and Kyphoplasty Device Annual Revenue by Geographic Region (2019-2024) 4.2 World Historic Vertebroplasty and Kyphoplasty Device Market Size by Country/Region (2019-2024) 4.2.1 Global Vertebroplasty and Kyphoplasty Device Annual Sales by Country/Region (2019-2024) 4.2.2 Global Vertebroplasty and Kyphoplasty Device Annual Revenue by Country/Region (2019-2024) 4.3 Americas Vertebroplasty and Kyphoplasty Device Sales Growth 4.4 APAC Vertebroplasty and Kyphoplasty Device Sales Growth 4.5 Europe Vertebroplasty and Kyphoplasty Device Sales Growth 4.6 Middle East & Africa Vertebroplasty and Kyphoplasty Device Sales Growth 5 Americas 5.1 Americas Vertebroplasty and Kyphoplasty Device Sales by Country 5.1.1 Americas Vertebroplasty and Kyphoplasty Device Sales by Country (2019-2024) 5.1.2 Americas Vertebroplasty and Kyphoplasty Device Revenue by Country (2019-2024) 5.2 Americas Vertebroplasty and Kyphoplasty Device Sales by Type 5.3 Americas Vertebroplasty and Kyphoplasty Device Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Vertebroplasty and Kyphoplasty Device Sales by Region 6.1.1 APAC Vertebroplasty and Kyphoplasty Device Sales by Region (2019-2024) 6.1.2 APAC Vertebroplasty and Kyphoplasty Device Revenue by Region (2019-2024) 6.2 APAC Vertebroplasty and Kyphoplasty Device Sales by Type 6.3 APAC Vertebroplasty and Kyphoplasty Device Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Vertebroplasty and Kyphoplasty Device by Country 7.1.1 Europe Vertebroplasty and Kyphoplasty Device Sales by Country (2019-2024) 7.1.2 Europe Vertebroplasty and Kyphoplasty Device Revenue by Country (2019-2024) 7.2 Europe Vertebroplasty and Kyphoplasty Device Sales by Type 7.3 Europe Vertebroplasty and Kyphoplasty Device Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Vertebroplasty and Kyphoplasty Device by Country 8.1.1 Middle East & Africa Vertebroplasty and Kyphoplasty Device Sales by Country (2019-2024) 8.1.2 Middle East & Africa Vertebroplasty and Kyphoplasty Device Revenue by Country (2019-2024) 8.2 Middle East & Africa Vertebroplasty and Kyphoplasty Device Sales by Type 8.3 Middle East & Africa Vertebroplasty and Kyphoplasty Device Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Vertebroplasty and Kyphoplasty Device 10.3 Manufacturing Process Analysis of Vertebroplasty and Kyphoplasty Device 10.4 Industry Chain Structure of Vertebroplasty and Kyphoplasty Device 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Vertebroplasty and Kyphoplasty Device Distributors 11.3 Vertebroplasty and Kyphoplasty Device Customer 12 World Forecast Review for Vertebroplasty and Kyphoplasty Device by Geographic Region 12.1 Global Vertebroplasty and Kyphoplasty Device Market Size Forecast by Region 12.1.1 Global Vertebroplasty and Kyphoplasty Device Forecast by Region (2025-2030) 12.1.2 Global Vertebroplasty and Kyphoplasty Device Annual Revenue Forecast by Region (2025-2030) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Vertebroplasty and Kyphoplasty Device Forecast by Type 12.7 Global Vertebroplasty and Kyphoplasty Device Forecast by Application 13 Key Players Analysis 13.1 Medtronic 13.1.1 Medtronic Company Information 13.1.2 Medtronic Vertebroplasty and Kyphoplasty Device Product Portfolios and Specifications 13.1.3 Medtronic Vertebroplasty and Kyphoplasty Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.1.4 Medtronic Main Business Overview 13.1.5 Medtronic Latest Developments 13.2 Stryker 13.2.1 Stryker Company Information 13.2.2 Stryker Vertebroplasty and Kyphoplasty Device Product Portfolios and Specifications 13.2.3 Stryker Vertebroplasty and Kyphoplasty Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.2.4 Stryker Main Business Overview 13.2.5 Stryker Latest Developments 13.3 DePuy Synthes (Johnson & Johnson) 13.3.1 DePuy Synthes (Johnson & Johnson) Company Information 13.3.2 DePuy Synthes (Johnson & Johnson) Vertebroplasty and Kyphoplasty Device Product Portfolios and Specifications 13.3.3 DePuy Synthes (Johnson & Johnson) Vertebroplasty and Kyphoplasty Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.3.4 DePuy Synthes (Johnson & Johnson) Main Business Overview 13.3.5 DePuy Synthes (Johnson & Johnson) Latest Developments 13.4 Globus Medical 13.4.1 Globus Medical Company Information 13.4.2 Globus Medical Vertebroplasty and Kyphoplasty Device Product Portfolios and Specifications 13.4.3 Globus Medical Vertebroplasty and Kyphoplasty Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.4.4 Globus Medical Main Business Overview 13.4.5 Globus Medical Latest Developments 13.5 Merit Medical Systems 13.5.1 Merit Medical Systems Company Information 13.5.2 Merit Medical Systems Vertebroplasty and Kyphoplasty Device Product Portfolios and Specifications 13.5.3 Merit Medical Systems Vertebroplasty and Kyphoplasty Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.5.4 Merit Medical Systems Main Business Overview 13.5.5 Merit Medical Systems Latest Developments 13.6 BMK Global Medical Company 13.6.1 BMK Global Medical Company Company Information 13.6.2 BMK Global Medical Company Vertebroplasty and Kyphoplasty Device Product Portfolios and Specifications 13.6.3 BMK Global Medical Company Vertebroplasty and Kyphoplasty Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.6.4 BMK Global Medical Company Main Business Overview 13.6.5 BMK Global Medical Company Latest Developments 13.7 IZI Medial Products 13.7.1 IZI Medial Products Company Information 13.7.2 IZI Medial Products Vertebroplasty and Kyphoplasty Device Product Portfolios and Specifications 13.7.3 IZI Medial Products Vertebroplasty and Kyphoplasty Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.7.4 IZI Medial Products Main Business Overview 13.7.5 IZI Medial Products Latest Developments 13.8 Zavation 13.8.1 Zavation Company Information 13.8.2 Zavation Vertebroplasty and Kyphoplasty Device Product Portfolios and Specifications 13.8.3 Zavation Vertebroplasty and Kyphoplasty Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.8.4 Zavation Main Business Overview 13.8.5 Zavation Latest Developments 13.9 G21 Srl 13.9.1 G21 Srl Company Information 13.9.2 G21 Srl Vertebroplasty and Kyphoplasty Device Product Portfolios and Specifications 13.9.3 G21 Srl Vertebroplasty and Kyphoplasty Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.9.4 G21 Srl Main Business Overview 13.9.5 G21 Srl Latest Developments 13.10 Joline 13.10.1 Joline Company Information 13.10.2 Joline Vertebroplasty and Kyphoplasty Device Product Portfolios and Specifications 13.10.3 Joline Vertebroplasty and Kyphoplasty Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.10.4 Joline Main Business Overview 13.10.5 Joline Latest Developments 13.11 Spine Wave 13.11.1 Spine Wave Company Information 13.11.2 Spine Wave Vertebroplasty and Kyphoplasty Device Product Portfolios and Specifications 13.11.3 Spine Wave Vertebroplasty and Kyphoplasty Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.11.4 Spine Wave Main Business Overview 13.11.5 Spine Wave Latest Developments 13.12 Teknimed 13.12.1 Teknimed Company Information 13.12.2 Teknimed Vertebroplasty and Kyphoplasty Device Product Portfolios and Specifications 13.12.3 Teknimed Vertebroplasty and Kyphoplasty Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.12.4 Teknimed Main Business Overview 13.12.5 Teknimed Latest Developments 13.13 PanMed 13.13.1 PanMed Company Information 13.13.2 PanMed Vertebroplasty and Kyphoplasty Device Product Portfolios and Specifications 13.13.3 PanMed Vertebroplasty and Kyphoplasty Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.13.4 PanMed Main Business Overview 13.13.5 PanMed Latest Developments 13.14 Biopsybell 13.14.1 Biopsybell Company Information 13.14.2 Biopsybell Vertebroplasty and Kyphoplasty Device Product Portfolios and Specifications 13.14.3 Biopsybell Vertebroplasty and Kyphoplasty Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.14.4 Biopsybell Main Business Overview 13.14.5 Biopsybell Latest Developments 14 Research Findings and Conclusion
SummaryAccording to our LPI (LP Information) latest study, the global Vertebroplasty and Kyphoplasty Device market size was valued at US$ 1207.2 million in 2023. With growing demand in downstream market, the Vertebroplasty and Kyphoplasty Device is forecast to a readjusted size of US$ 1543 million by 2030 with a CAGR of 3.6% during review period. Table of Contents1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Vertebroplasty and Kyphoplasty Device Annual Sales 2019-2030 2.1.2 World Current & Future Analysis for Vertebroplasty and Kyphoplasty Device by Geographic Region, 2019, 2023 & 2030 2.1.3 World Current & Future Analysis for Vertebroplasty and Kyphoplasty Device by Country/Region, 2019, 2023 & 2030 2.2 Vertebroplasty and Kyphoplasty Device Segment by Type 2.2.1 Needles 2.2.2 Balloons 2.2.3 Cement Mixing and Delivery Devices 2.3 Vertebroplasty and Kyphoplasty Device Sales by Type 2.3.1 Global Vertebroplasty and Kyphoplasty Device Sales Market Share by Type (2019-2024) 2.3.2 Global Vertebroplasty and Kyphoplasty Device Revenue and Market Share by Type (2019-2024) 2.3.3 Global Vertebroplasty and Kyphoplasty Device Sale Price by Type (2019-2024) 2.4 Vertebroplasty and Kyphoplasty Device Segment by Application 2.4.1 Hospital 2.4.2 Ambulatory Surgery Center 2.4.3 Others 2.5 Vertebroplasty and Kyphoplasty Device Sales by Application 2.5.1 Global Vertebroplasty and Kyphoplasty Device Sale Market Share by Application (2019-2024) 2.5.2 Global Vertebroplasty and Kyphoplasty Device Revenue and Market Share by Application (2019-2024) 2.5.3 Global Vertebroplasty and Kyphoplasty Device Sale Price by Application (2019-2024) 3 Global Vertebroplasty and Kyphoplasty Device by Company 3.1 Global Vertebroplasty and Kyphoplasty Device Breakdown Data by Company 3.1.1 Global Vertebroplasty and Kyphoplasty Device Annual Sales by Company (2019-2024) 3.1.2 Global Vertebroplasty and Kyphoplasty Device Sales Market Share by Company (2019-2024) 3.2 Global Vertebroplasty and Kyphoplasty Device Annual Revenue by Company (2019-2024) 3.2.1 Global Vertebroplasty and Kyphoplasty Device Revenue by Company (2019-2024) 3.2.2 Global Vertebroplasty and Kyphoplasty Device Revenue Market Share by Company (2019-2024) 3.3 Global Vertebroplasty and Kyphoplasty Device Sale Price by Company 3.4 Key Manufacturers Vertebroplasty and Kyphoplasty Device Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Vertebroplasty and Kyphoplasty Device Product Location Distribution 3.4.2 Players Vertebroplasty and Kyphoplasty Device Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Vertebroplasty and Kyphoplasty Device by Geographic Region 4.1 World Historic Vertebroplasty and Kyphoplasty Device Market Size by Geographic Region (2019-2024) 4.1.1 Global Vertebroplasty and Kyphoplasty Device Annual Sales by Geographic Region (2019-2024) 4.1.2 Global Vertebroplasty and Kyphoplasty Device Annual Revenue by Geographic Region (2019-2024) 4.2 World Historic Vertebroplasty and Kyphoplasty Device Market Size by Country/Region (2019-2024) 4.2.1 Global Vertebroplasty and Kyphoplasty Device Annual Sales by Country/Region (2019-2024) 4.2.2 Global Vertebroplasty and Kyphoplasty Device Annual Revenue by Country/Region (2019-2024) 4.3 Americas Vertebroplasty and Kyphoplasty Device Sales Growth 4.4 APAC Vertebroplasty and Kyphoplasty Device Sales Growth 4.5 Europe Vertebroplasty and Kyphoplasty Device Sales Growth 4.6 Middle East & Africa Vertebroplasty and Kyphoplasty Device Sales Growth 5 Americas 5.1 Americas Vertebroplasty and Kyphoplasty Device Sales by Country 5.1.1 Americas Vertebroplasty and Kyphoplasty Device Sales by Country (2019-2024) 5.1.2 Americas Vertebroplasty and Kyphoplasty Device Revenue by Country (2019-2024) 5.2 Americas Vertebroplasty and Kyphoplasty Device Sales by Type 5.3 Americas Vertebroplasty and Kyphoplasty Device Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Vertebroplasty and Kyphoplasty Device Sales by Region 6.1.1 APAC Vertebroplasty and Kyphoplasty Device Sales by Region (2019-2024) 6.1.2 APAC Vertebroplasty and Kyphoplasty Device Revenue by Region (2019-2024) 6.2 APAC Vertebroplasty and Kyphoplasty Device Sales by Type 6.3 APAC Vertebroplasty and Kyphoplasty Device Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Vertebroplasty and Kyphoplasty Device by Country 7.1.1 Europe Vertebroplasty and Kyphoplasty Device Sales by Country (2019-2024) 7.1.2 Europe Vertebroplasty and Kyphoplasty Device Revenue by Country (2019-2024) 7.2 Europe Vertebroplasty and Kyphoplasty Device Sales by Type 7.3 Europe Vertebroplasty and Kyphoplasty Device Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Vertebroplasty and Kyphoplasty Device by Country 8.1.1 Middle East & Africa Vertebroplasty and Kyphoplasty Device Sales by Country (2019-2024) 8.1.2 Middle East & Africa Vertebroplasty and Kyphoplasty Device Revenue by Country (2019-2024) 8.2 Middle East & Africa Vertebroplasty and Kyphoplasty Device Sales by Type 8.3 Middle East & Africa Vertebroplasty and Kyphoplasty Device Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Vertebroplasty and Kyphoplasty Device 10.3 Manufacturing Process Analysis of Vertebroplasty and Kyphoplasty Device 10.4 Industry Chain Structure of Vertebroplasty and Kyphoplasty Device 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Vertebroplasty and Kyphoplasty Device Distributors 11.3 Vertebroplasty and Kyphoplasty Device Customer 12 World Forecast Review for Vertebroplasty and Kyphoplasty Device by Geographic Region 12.1 Global Vertebroplasty and Kyphoplasty Device Market Size Forecast by Region 12.1.1 Global Vertebroplasty and Kyphoplasty Device Forecast by Region (2025-2030) 12.1.2 Global Vertebroplasty and Kyphoplasty Device Annual Revenue Forecast by Region (2025-2030) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Vertebroplasty and Kyphoplasty Device Forecast by Type 12.7 Global Vertebroplasty and Kyphoplasty Device Forecast by Application 13 Key Players Analysis 13.1 Medtronic 13.1.1 Medtronic Company Information 13.1.2 Medtronic Vertebroplasty and Kyphoplasty Device Product Portfolios and Specifications 13.1.3 Medtronic Vertebroplasty and Kyphoplasty Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.1.4 Medtronic Main Business Overview 13.1.5 Medtronic Latest Developments 13.2 Stryker 13.2.1 Stryker Company Information 13.2.2 Stryker Vertebroplasty and Kyphoplasty Device Product Portfolios and Specifications 13.2.3 Stryker Vertebroplasty and Kyphoplasty Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.2.4 Stryker Main Business Overview 13.2.5 Stryker Latest Developments 13.3 DePuy Synthes (Johnson & Johnson) 13.3.1 DePuy Synthes (Johnson & Johnson) Company Information 13.3.2 DePuy Synthes (Johnson & Johnson) Vertebroplasty and Kyphoplasty Device Product Portfolios and Specifications 13.3.3 DePuy Synthes (Johnson & Johnson) Vertebroplasty and Kyphoplasty Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.3.4 DePuy Synthes (Johnson & Johnson) Main Business Overview 13.3.5 DePuy Synthes (Johnson & Johnson) Latest Developments 13.4 Globus Medical 13.4.1 Globus Medical Company Information 13.4.2 Globus Medical Vertebroplasty and Kyphoplasty Device Product Portfolios and Specifications 13.4.3 Globus Medical Vertebroplasty and Kyphoplasty Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.4.4 Globus Medical Main Business Overview 13.4.5 Globus Medical Latest Developments 13.5 Merit Medical Systems 13.5.1 Merit Medical Systems Company Information 13.5.2 Merit Medical Systems Vertebroplasty and Kyphoplasty Device Product Portfolios and Specifications 13.5.3 Merit Medical Systems Vertebroplasty and Kyphoplasty Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.5.4 Merit Medical Systems Main Business Overview 13.5.5 Merit Medical Systems Latest Developments 13.6 BMK Global Medical Company 13.6.1 BMK Global Medical Company Company Information 13.6.2 BMK Global Medical Company Vertebroplasty and Kyphoplasty Device Product Portfolios and Specifications 13.6.3 BMK Global Medical Company Vertebroplasty and Kyphoplasty Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.6.4 BMK Global Medical Company Main Business Overview 13.6.5 BMK Global Medical Company Latest Developments 13.7 IZI Medial Products 13.7.1 IZI Medial Products Company Information 13.7.2 IZI Medial Products Vertebroplasty and Kyphoplasty Device Product Portfolios and Specifications 13.7.3 IZI Medial Products Vertebroplasty and Kyphoplasty Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.7.4 IZI Medial Products Main Business Overview 13.7.5 IZI Medial Products Latest Developments 13.8 Zavation 13.8.1 Zavation Company Information 13.8.2 Zavation Vertebroplasty and Kyphoplasty Device Product Portfolios and Specifications 13.8.3 Zavation Vertebroplasty and Kyphoplasty Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.8.4 Zavation Main Business Overview 13.8.5 Zavation Latest Developments 13.9 G21 Srl 13.9.1 G21 Srl Company Information 13.9.2 G21 Srl Vertebroplasty and Kyphoplasty Device Product Portfolios and Specifications 13.9.3 G21 Srl Vertebroplasty and Kyphoplasty Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.9.4 G21 Srl Main Business Overview 13.9.5 G21 Srl Latest Developments 13.10 Joline 13.10.1 Joline Company Information 13.10.2 Joline Vertebroplasty and Kyphoplasty Device Product Portfolios and Specifications 13.10.3 Joline Vertebroplasty and Kyphoplasty Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.10.4 Joline Main Business Overview 13.10.5 Joline Latest Developments 13.11 Spine Wave 13.11.1 Spine Wave Company Information 13.11.2 Spine Wave Vertebroplasty and Kyphoplasty Device Product Portfolios and Specifications 13.11.3 Spine Wave Vertebroplasty and Kyphoplasty Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.11.4 Spine Wave Main Business Overview 13.11.5 Spine Wave Latest Developments 13.12 Teknimed 13.12.1 Teknimed Company Information 13.12.2 Teknimed Vertebroplasty and Kyphoplasty Device Product Portfolios and Specifications 13.12.3 Teknimed Vertebroplasty and Kyphoplasty Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.12.4 Teknimed Main Business Overview 13.12.5 Teknimed Latest Developments 13.13 PanMed 13.13.1 PanMed Company Information 13.13.2 PanMed Vertebroplasty and Kyphoplasty Device Product Portfolios and Specifications 13.13.3 PanMed Vertebroplasty and Kyphoplasty Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.13.4 PanMed Main Business Overview 13.13.5 PanMed Latest Developments 13.14 Biopsybell 13.14.1 Biopsybell Company Information 13.14.2 Biopsybell Vertebroplasty and Kyphoplasty Device Product Portfolios and Specifications 13.14.3 Biopsybell Vertebroplasty and Kyphoplasty Device Sales, Revenue, Price and Gross Margin (2019-2024) 13.14.4 Biopsybell Main Business Overview 13.14.5 Biopsybell Latest Developments 14 Research Findings and Conclusion
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
LP Information社の医療分野での最新刊レポート本レポートと同じKEY WORD()の最新刊レポート
よくあるご質問LP Information社はどのような調査会社ですか?LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/19 10:26 155.48 円 165.11 円 199.74 円 |